Bladder cancer is among the ten most common cancers globally, causes considerable
morbidity and mortality and is, therefore, a substantial burden for health-care systems. The …

Context The incidence of bladder cancer is three to four times greater in men than in women.
However, women are diagnosed with more advanced disease at presentation and have less …

CONTEXT: Urothelial bladder cancer (UBC) is a disease of significant morbidity and
mortality. It is important to understand the risk factors of this disease. OBJECTIVE: To …

Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent
recurrence of non-invasive disease. Improved prognostic biomarkers and localized therapy …

Purpose: Urothelial carcinoma of the bladder is the 4th most common malignancy in men
and the 8th most common cause of male cancer death in the United States. Conversely …

Purpose Use of molecular markers in urine, tissue or blood offers potential opportunities to
improve understanding of bladder cancer biology which may help identify disease earlier …

Objective The aim of this study was to summarize and analyze the current evidence
regarding the prognostic and predictive value of preoperative neutrophil-to-lymphocyte ratio …

A gender discrepancy exists in the incidence of both urothelial and kidney carcinomas, with
more men presenting with these cancers than women. Men have a threefold greater risk of …

More than 350,000 new cases of bladder cancer are diagnosed worldwide each year; the
vast majority (> 90%) of these are transitional cell carcinomas (TCC). The most important risk …

Context Cigarette smoking is an established risk factor for urothelial carcinoma. Objective To
elucidate the association between pretreatment smoking status, cumulative exposure, and …